A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)-Reference-Cited by-同舟云学术

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Published:1999-06-25 Issue:10 Volume:80 Page:1595-1598
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Cascinu S,Silva R R,Barni S,Labianca R,Frontini L,Piazza E,Pancera G,Giordani P,Giuliodori L,Pessi M A,Fusco V,Luporini G,Cellerino R,Catalano G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6690568.pdf

Reference22 articles.

1. Ahlgren, J. D. (1996). Chemotherapy for pancreatic cancer. Cancer 78: 654–663.

2. Burris, III H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., Nelson, R., Dorr, F. A., Stephens, C. D. & Von Hoff, D. D. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403–2413.

3. Carmichael, J., Fink, U., Russel, R. C. G., Spittle, M. F., Harris, A. & Spiessl, G. (1995). Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 73: 101–105.

4. Casper, E. S., Green, M. R., Kelsen, D. P., Heelan, R. T., Brown, T. D. & Flombaum, C. D. (1994). Phase II trial of gemcitabine in patients with adenocarcinoma of the pancreas. Invest New Drug 12: 29–35.

5. DeCaprio, J. A., Mayer, R. J., Gonin, R. & Arbuck, S. G. (1991). Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial. J Clin Oncol 9: 2128–2133.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DRSPRING: Graph convolutional network (GCN)-Based drug synergy prediction utilizing drug-induced gene expression profile;Computers in Biology and Medicine;2024-05

2. IND;Translational Orthopedics;2024

3. Stem cell factor modulates HIF‐1α levels and diminishes 5‐FU sensitivity in 5‐FU resistant pancreatic cells by altering the anabolic glucose metabolism;Journal of Biochemical and Molecular Toxicology;2023-09-17

4. SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis;Open Medicine;2020-10-22

5. Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer;Pancreas;2019-11